Latest News
Research & Innovation
Arnethea Sutton selected for National Cancer Institute Early Investigator Advancement Program
Feb 27, 2023
Arnethea Sutton, Ph.D., a member of the Cancer Prevention and Control research program at VCU Massey Cancer Center and an assistant professor in the Department of Kinesiology and Health Sciences in the VCU College of Humanities and Sciences, has been named to the second cohort of the National Cancer Institute’s Early Investigator Advancement Program (EIAP).
The EIAP aims to enhance professional skills, guide preparation of an R01 grant application, provide access to a mentoring and peer network, and grow a community of emerging independent investigators from diverse backgrounds. Ultimately, the EIAP looks to facilitate the transition from junior investigator to independent investigator. Sutton was one of 25 scholars from across the country selected for the EIAP.
Sutton, who studies the impact of sociodemographic, health care and psychosocial factors on racial disparities in cardiovascular toxicities experienced by breast cancer survivors, looks forward to the program.
“I hope to gain more support, in addition to what I receive here at VCU, that will be invaluable as I work toward my first R01,” Sutton said. “This program will provide a mentor(s) with expertise in disparities in cardio-oncology, and it will keep me very focused given the number of one-on-one meetings and deadlines for varying components of the grant application.”
Sutton earned her Ph.D. in health-related sciences from VCU in 2017, and most recently completed a T32 postdoctoral fellowship in the Department of Health Behavior and Policy at VCU.
Written by: Alexis Finc
Related News
Research & Innovation, Community Engagement
Virginia public health leaders turn community priorities into actionJun 9, 2026
Research & Innovation, Clinical Care
Massey shares findings on GLP-1 use and cancer outcomes, other innovative research at ASCO Annual Meeting 2026Jun 2, 2026
Research & Innovation
National Cancer Research Month: Each discovery adds a little piece to the puzzleMay 29, 2026
Get access to new, innovative care
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Find a provider
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.